Concise review: primary cilia: control centers for stem cell lineage specification and potential targets for cell-based therapies

JC Bodle, EG Loboa - Stem cells, 2016 - academic.oup.com
Stem cells, 2016academic.oup.com
Directing stem cell lineage commitment prevails as the holy grail of translational stem cell
research, particularly to those interested in the application of mesenchymal stem cells and
adipose-derived stem cells in tissue engineering. However, elucidating the mechanisms
underlying their phenotypic specification persists as an active area of research. In recent
studies, the primary cilium structure has been intimately associated with defining cell
phenotype, maintaining stemness, as well as functioning in a chemo, electro, and …
Abstract
Directing stem cell lineage commitment prevails as the holy grail of translational stem cell research, particularly to those interested in the application of mesenchymal stem cells and adipose-derived stem cells in tissue engineering. However, elucidating the mechanisms underlying their phenotypic specification persists as an active area of research. In recent studies, the primary cilium structure has been intimately associated with defining cell phenotype, maintaining stemness, as well as functioning in a chemo, electro, and mechanosensory capacity in progenitor and committed cell types. Many hypothesize that the primary cilium may indeed be another important player in defining and controlling cell phenotype, concomitant with lineage-dictated cytoskeletal dynamics. Many of the studies on the primary cilium have emerged from disparate areas of biological research, and crosstalk amongst these areas of research is just beginning. To date, there has not been a thorough review of how primary cilia fit into the current paradigm of stem cell differentiation and this review aims to summarize the current cilia work in this context. The goal of this review is to highlight the cilium's function and integrate this knowledge into the working knowledge of stem cell biologists and tissue engineers developing regenerative medicine technologies.
Oxford University Press